Liu ZF - Search Results

1

Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer.

Zhang SJ, Hu Y, Qian HL, Jiao SC, Liu ZF, Tao HT, Han L. Zhang SJ, et al. Among authors: liu zf. Asian Pac J Cancer Prev. 2013;14(6):3937-40. doi: 10.7314/apjcp.2013.14.6.3937. Asian Pac J Cancer Prev. 2013. PMID: 23886210 Free article.

2

[Clinical research of 120 cases of primary small intestine malignant tumor].

Liu ZF, Jiao SC, Yang JL, Dai GH. Liu ZF, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Mar;30(3):602-4, 607. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 20335150 Chinese.

3

Meta-analysis of ALDH2 variants and esophageal cancer in Asians.

Fang P, Jiao S, Zhang X, Liu Z, Wang H, Gao Y, Luo H, Chen T, Shi L. Fang P, et al. Asian Pac J Cancer Prev. 2011;12(10):2623-7. Asian Pac J Cancer Prev. 2011. PMID: 22320964 Free article.

4

Efficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials.

Fang P, Hu JH, Cheng ZG, Liu ZF, Wang JL, Jiao SC. Fang P, et al. Among authors: liu zf. PLoS One. 2012;7(12):e49717. doi: 10.1371/journal.pone.0049717. Epub 2012 Dec 19. PLoS One. 2012. PMID: 23284624 Free PMC article. Review.

5

[Clinical characteristics and prognostic factors of malignancy-associated hypercalcemia in squamous cell carcinoma].

Zhang SJ, Hu Y, Jiao SC, Liu ZF, Tao HT. Zhang SJ, et al. Among authors: liu zf. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Dec;34(6):585-9. doi: 10.3881/j.issn.1000-503X.2012.06.009. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012. PMID: 23286403 Chinese.

6

Analysis on survival and prognostic factors for cancer patients with malignancy-associated hypercalcemia.

Zhang SJ, Hu Y, Cao J, Qian HL, Jiao SC, Liu ZF, Tao HT, Han L. Zhang SJ, et al. Among authors: liu zf. Asian Pac J Cancer Prev. 2014 Jan;14(11):6715-9. doi: 10.7314/apjcp.2013.14.11.6715. Asian Pac J Cancer Prev. 2014. PMID: 24377594 Free article.

7

A phase II open-label clinical study of comparing nab-paclitaxel with pemetrexed as second-line chemotherapy for patients with stage IIIB/IV non-small-cell lung cancer.

Liu Z, Wei Z, Hu Y, Gao F, Hao L, Fang P, Sun S, Li J, Jiao S. Liu Z, et al. Med Oncol. 2015 Aug;32(8):216. doi: 10.1007/s12032-015-0660-5. Epub 2015 Jul 14. Med Oncol. 2015. PMID: 26168982 Clinical Trial.

8

Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients.

Zhang Y, Zhao Y, Sun S, Liu Z, Zhang Y, Jiao S. Zhang Y, et al. Tumour Biol. 2016 Aug;37(8):10155-60. doi: 10.1007/s13277-015-4662-x. Epub 2016 Jan 29. Tumour Biol. 2016. PMID: 26831656

9

Impact of Lymphocyte Subsets on Chemotherapy Efficacy and Long-term Survival of Patients with Advanced Non-small-cell Lung Cancer.

Wei Z, Zhang W, Gao F, Wu Y, Zhang G, Liu Z, Jiao S. Wei Z, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Jun 20;39(3):371-376. doi: 10.3881/j.issn.1000-503X.2017.03.012. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017. PMID: 28695808

10

Efficacy and safety of apatinib as second-line therapy for advanced gastric cancer: a single-center observational study.

Zhang Y, Gou M, Han C, Li J, Wang L, Qiao Q, Hu Y, Bai L, Liu Z. Zhang Y, et al. Anticancer Drugs. 2018 Feb;29(2):184-189. doi: 10.1097/CAD.0000000000000582. Anticancer Drugs. 2018. PMID: 29215372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

607 results

Search Page

Filters